Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
about
Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentTranslating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulatesThe relationship between the MMP system, adrenoceptors and phosphoprotein phosphatasesPathogenesis of chagas' disease: parasite persistence and autoimmunityComparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditisMesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis.Matrix metalloproteinases: drug targets for myocardial infarction.Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.Carvedilol protects against apoptotic cell death induced by cisplatin in renal tubular epithelial cells.Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection with Trypanosoma cruziAntimicrobial agents for myocarditis: target the pathway, not the pathogen.Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice.Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.
P2860
Q26744257-052F41D2-1029-4E06-A84B-E682599CD4A5Q26865099-E5A20E4F-2241-4221-B72B-CD159DA8A33FQ27003263-1678F287-96BA-4057-A467-1E908E2C812DQ28742827-60B1EC91-C47F-423F-8665-B805AB05BF12Q34326097-07FF8A32-2DB8-4537-B816-E4487CB68B9DQ34345561-439F2027-0C9B-41A5-BF22-EDFC5F5F8688Q36560495-AB2EB800-68A5-4E18-80A2-CF48075FF405Q36931868-72494771-66B0-4F0C-BC16-6E7786C7CFB0Q37308645-3F70E03F-8151-4BF5-BC4D-F713B4B90201Q37380847-B16E5F17-1C75-49F0-8C2E-8F0A867819CEQ39304222-70643B63-51E4-4294-A8B2-EBF85F74217DQ42102813-70D67DAA-A99E-44F7-BCFA-444403C3B8C4Q45925637-47EFEC63-4F10-4F4C-A621-46CAA5D958F9Q46717362-8FBBA64E-7E7B-4AF6-A0E7-9DC3A336CB7CQ48400393-6219F1F5-892C-4A06-9A2D-38A908647AFE
P2860
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Carvedilol improves left ventr ...... d a modulated immune response.
@en
Carvedilol improves left ventr ...... d a modulated immune response.
@nl
type
label
Carvedilol improves left ventr ...... d a modulated immune response.
@en
Carvedilol improves left ventr ...... d a modulated immune response.
@nl
prefLabel
Carvedilol improves left ventr ...... d a modulated immune response.
@en
Carvedilol improves left ventr ...... d a modulated immune response.
@nl
P2093
P2860
P1476
Carvedilol improves left ventr ...... d a modulated immune response.
@en
P2093
Anneke Weitz
Carsten Tschope
Dirk Westermann
Heinz Zeichhardt
Heinz-Peter Schultheiss
Kumaran Chandrasekharan
Lothar Peter Schwimmbeck
Matthias Pauschinger
Susanne Rutschow
P2860
P304
P356
10.1016/J.EJHEART.2004.07.002
P577
2005-06-01T00:00:00Z